Back to Search Start Over

New Peak Detection Performance Metrics from the MAM Consortium Interlaboratory Study.

Authors :
Mouchahoir T
Schiel JE
Rogers R
Heckert A
Place BJ
Ammerman A
Li X
Robinson T
Schmidt B
Chumsae CM
Li X
Manuilov AV
Yan B
Staples GO
Ren D
Veach AJ
Wang D
Yared W
Sosic Z
Wang Y
Zang L
Leone AM
Liu P
Ludwig R
Tao L
Wu W
Cansizoglu A
Hanneman A
Adams GW
Perdivara I
Walker H
Wilson M
Brandenburg A
DeGraan-Weber N
Gotta S
Shambaugh J
Alvarez M
Yu XC
Cao L
Shao C
Mahan A
Nanda H
Nields K
Nightlinger N
Barysz HM
Jahn M
Niu B
Wang J
Leo G
Sepe N
Liu YH
Patel BA
Richardson D
Wang Y
Tizabi D
Borisov OV
Lu Y
Maynard EL
Gruhler A
Haselmann KF
Krogh TN
Sönksen CP
Letarte S
Shen S
Boggio K
Johnson K
Ni W
Patel H
Ripley D
Rouse JC
Zhang Y
Daniels C
Dawdy A
Friese O
Powers TW
Sperry JB
Woods J
Carlson E
Sen KI
Skilton SJ
Busch M
Lund A
Stapels M
Guo X
Heidelberger S
Kaluarachchi H
McCarthy S
Kim J
Zhen J
Zhou Y
Rogstad S
Wang X
Fang J
Chen W
Yu YQ
Hoogerheide JG
Scott R
Yuan H
Source :
Journal of the American Society for Mass Spectrometry [J Am Soc Mass Spectrom] 2021 Apr 07; Vol. 32 (4), pp. 913-928. Date of Electronic Publication: 2021 Mar 12.
Publication Year :
2021

Abstract

The Multi-Attribute Method (MAM) Consortium was initially formed as a venue to harmonize best practices, share experiences, and generate innovative methodologies to facilitate widespread integration of the MAM platform, which is an emerging ultra-high-performance liquid chromatography-mass spectrometry application. Successful implementation of MAM as a purity-indicating assay requires new peak detection (NPD) of potential process- and/or product-related impurities. The NPD interlaboratory study described herein was carried out by the MAM Consortium to report on the industry-wide performance of NPD using predigested samples of the NISTmAb Reference Material 8671. Results from 28 participating laboratories show that the NPD parameters being utilized across the industry are representative of high-resolution MS performance capabilities. Certain elements of NPD, including common sources of variability in the number of new peaks detected, that are critical to the performance of the purity function of MAM were identified in this study and are reported here as a means to further refine the methodology and accelerate adoption into manufacturer-specific protein therapeutic product life cycles.

Details

Language :
English
ISSN :
1879-1123
Volume :
32
Issue :
4
Database :
MEDLINE
Journal :
Journal of the American Society for Mass Spectrometry
Publication Type :
Academic Journal
Accession number :
33710905
Full Text :
https://doi.org/10.1021/jasms.0c00415